Mural Oncology plc (MURA)
NASDAQ: MURA · Real-Time Price · USD
3.180
+0.040 (1.27%)
At close: Dec 20, 2024, 4:00 PM
3.160
-0.020 (-0.63%)
After-hours: Dec 20, 2024, 6:54 PM EST
Mural Oncology Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Mural Oncology stock have an average target of 16, with a low estimate of 13 and a high estimate of 18. The average target predicts an increase of 403.14% from the current stock price of 3.18.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 14, 2024.
Analyst Ratings
The average analyst rating for Mural Oncology stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +466.04% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +466.04% | Nov 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +466.04% | Oct 17, 2024 |
| Raymond James | Raymond James | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +466.04% | Oct 4, 2024 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +371.70% | Jun 28, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-7.69
from -12.43
EPS Next Year
-4.81
from -7.69
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | 27.4M | |||
| Avg | n/a | n/a | 11.5M | |||
| Low | n/a | n/a | 3.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -7.89 | -4.10 | -2.39 | |||
| Avg | -7.69 | -4.81 | -3.03 | |||
| Low | -7.44 | -5.21 | -3.25 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.